Bio-Rad Laboratories, Inc. Share Price
Stocks
BIO
US0905722072
Medical Equipment, Supplies & Distribution
|
Market Closed -
NYSE
01:30:03 14/08/2026 am IST
|
5-day change | 1st Jan Change | ||
| 361.19 USD | -0.25% |
|
+5.48% | +19.21% |
| 07/08 | RBC Adjusts PT on Bio-Rad Laboratories to $390 From $370, Maintains Outperform Rating | MT |
| 05/08 | RBC Adjusts Price Target on Bio-Rad Laboratories to $370 From $320, Maintains Outperform Rating | MT |
| Market Cap | 953.51Cr 826.51Cr 774.79Cr 706.46Cr 1.33TCr 91TCr 1.35TCr 9.12TCr 3.56TCr 46TCr 3.58TCr 3.5TCr 1,52000Cr | P/E 2026 * |
43.4x | P/E 2027 * | 42.4x |
|---|---|---|---|---|---|
| Enterprise Value | 878.61Cr 761.58Cr 713.92Cr 650.96Cr 1.22TCr 84TCr 1.24TCr 8.41TCr 3.28TCr 42TCr 3.3TCr 3.23TCr 1,40000Cr | EV / Sales 2026 * |
3.41x | EV / Sales 2027 * | 3.25x |
| Free-Float |
60.2% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Bio-Rad Laboratories, Inc.
| 1 day | -0.25% | ||
| 1 week | +5.48% | ||
| Current month | +10.97% | ||
| 1 month | +21.38% | ||
| 3 months | +48.33% | ||
| 6 months | +40.78% | ||
| Current year | +19.21% |
| 1 week | 347.86 |  | 365 |
| 1 month | 285.39 | | 365 |
| Current year | 236.73 | | 365 |
| 1 year | 236.73 | | 365 |
| 3 years | 211.43 | | 406.44 |
| 5 years | 211.43 | | 832.7 |
| 10 years | 147.68 | | 832.7 |
| Manager | Title | Age | Since |
|---|---|---|---|
Norman Schwartz
CEO | Chief Executive Officer | 76 | 01/01/2003 |
| President | 61 | 09/09/2024 | |
Roop Lakkaraju
DFI | Director of Finance/CFO | 55 | 15/04/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Norman Schwartz
CHM | Chairman | 76 | 01/01/2012 |
Jeffrey Edwards
BRD | Director/Board Member | 73 | 25/04/2017 |
Gregory Hinckley
BRD | Director/Board Member | 79 | 25/04/2017 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 25/07/26 | Fiscal year | Executive/Senior Manager | 581 | 0.0027% | ||
| 24/04/26 | Fiscal year | Chief Financial Officer | 2,576 | 0.0117% | ||
| 06/11/25 | Sell | EVP, President, LSG | 700 | 0.0032% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.25% | +5.48% | +25.78% | -9.05% | 955.44Cr | |
| +0.32% | +3.07% | -14.01% | +5.66% | 19TCr | |
| -0.20% | +5.42% | -2.51% | +8.54% | 12TCr | |
| -1.32% | -4.62% | +6.52% | +65.45% | 6TCr | |
| -0.09% | +3.49% | +37.84% | +64.46% | 5.46TCr | |
| -0.88% | +2.77% | -7.14% | -35.54% | 5TCr | |
| +0.75% | +10.19% | +14.41% | -18.09% | 3.43TCr | |
| +0.23% | +3.10% | - | - | 3.11TCr | |
| -1.74% | -0.70% | +40.59% | -12.31% | 2.48TCr | |
| +1.43% | +12.01% | -3.33% | +25.23% | 2.41TCr | |
| Average | -0.18% | +3.87% | +10.91% | +10.48% | 5.97TCr | |
| Weighted average by Cap. | -0.11% | +3.20% | +1.39% | +12.99% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 257.33Cr 223.06Cr 209.1Cr 190.66Cr 358.74Cr 25TCr 364.48Cr 2.46TCr 961.18Cr 12TCr 966.1Cr 945.18Cr 41TCr | 263.35Cr 228.27Cr 213.99Cr 195.12Cr 367.13Cr 25TCr 373.01Cr 2.52TCr 983.66Cr 13TCr 988.69Cr 967.28Cr 42TCr |
| Net income | 22Cr 20Cr 18Cr 17Cr 31Cr 2.15TCr 32Cr 215.27Cr 84Cr 1.07TCr 84Cr 83Cr 3.59TCr | 23Cr 20Cr 19Cr 17Cr 32Cr 2.2TCr 33Cr 220.05Cr 86Cr 1.1TCr 86Cr 84Cr 3.67TCr |
| Net Debt | -75Cr -65Cr -61Cr -55Cr -104.42Cr -7.15TCr -106.09Cr -716.63Cr -279.77Cr -3.58TCr -281.2Cr -275.11Cr -12TCr | -97Cr -84Cr -78Cr -72Cr -134.59Cr -9.21TCr -136.74Cr -923.67Cr -360.6Cr -4.61TCr -362.45Cr -354.6Cr -15TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 13/26/13 | $361.19 | -0.25% | 2,07,469 |
| 12/26/12 | $362.08 | +1.64% | 2,33,885 |
| 11/26/11 | $356.25 | +0.48% | 2,51,919 |
| 10/26/10 | $354.54 | +0.59% | 2,21,108 |
| 07/26/07 | $352.47 | +2.93% | 2,66,854 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- BIO Stock
Select your edition
All financial news and data tailored to specific country editions
